Novel Alginate-Chitosan Composite Microspheres for Implant Delivery of Vancomycin and In Vivo Evaluation

In this study, vancomycin loaded alginate–chitosan composite microspheres were developed by emulsion cross‐linking method. The in vitro and vivo characterizations were done to evaluate the feasibility of application. Our experimental results showed that the emulsification cross‐linking technique app...

Full description

Saved in:
Bibliographic Details
Published inChemical biology & drug design Vol. 88; no. 3; pp. 434 - 440
Main Authors Mao, Yimin, Zhao, Ming, Ge, Yongbiao, Fan, Jiang
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.09.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this study, vancomycin loaded alginate–chitosan composite microspheres were developed by emulsion cross‐linking method. The in vitro and vivo characterizations were done to evaluate the feasibility of application. Our experimental results showed that the emulsification cross‐linking technique appeared to be a feasible method for the preparation of alginate–chitosan composite microspheres. The microspheres were spherical in shape and the mean particle size and drug loading were 25.3 ± 5.4 μm and 18.5 ± 2.3% respectively. A sustained vancomycin release was realized i.e. the amount of cumulative release increased in a time frame of 24 h to reach an amount i.e. ~68%. The model that fit best for vancomycin released from the microspheres was the Higuchi kinetic model with a correlation coefficient r = 0.9996. In vivo results showed that the application of microspheres not only reduced the toxicity, but also maintained effective drug concentration. In addition, no severe signs of epithelial necrosis and sloughing of epithelial cells were detected in histological studies. Vancomycin loaded alginate–chitosan composite microspheres were developed by emulsion cross‐linking method. The microspheres were spherical in shape and the mean particle size and drug loading were 25.3 ± 5.4 µm and 18.5 ± 2.3%. In vivo results showed that the application of microspheres not only reduced the toxicity, but also maintained effective drug concentration.
Bibliography:ArticleID:CBDD12771
National Natural Science Foundation of China - No. 81370107
ark:/67375/WNG-1Q6ZW3FD-Z
istex:326985FD4E089EF9598F776743086882D679A2DB
Shanghai Municipal Science and Technology Commission - No. 134119b1002
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1747-0277
1747-0285
DOI:10.1111/cbdd.12771